Victoria Sherwood, Irene M. Leigh  Journal of Investigative Dermatology 

Slides:



Advertisements
Similar presentations
Manifestation of Novel Social Challenges of the European Union in the Teaching Material of Medical Biotechnology Master’s Programmes at the University.
Advertisements

Wnt signaling in development and disease Vítězslav Bryja, PhD. Institute of Experimental Biology Faculty of Science, Masaryk University Brno, Czech Republic.
Smad3-dependent nuclear translocation of B-catenin is required for TGF-B1-induced proliferation of bone marrow- derivced adult human mesenchymal stem cells.
Volume 131, Issue 4, Pages (October 2006)
Nithya Krishnamurthy, Razelle Kurzrock  Cancer Treatment Reviews 
The Wnt signaling pathway in cancer
Volume 59, Issue 5, Pages (November 2013)
Biology and Treatment of Aggressive Fibromatosis or Desmoid Tumor
David Largaespada, Nancy Ratner  Cancer Cell 
Volume 12, Issue 2, Pages (February 2013)
c-Kit as a Novel Potential Therapeutic Target in Colorectal Cancer
Hematopoietic stem cell fate decisions are regulated by Wnt antagonists: Comparisons and current controversies  Corey J. Cain, Jennifer O. Manilay  Experimental.
Epithelial-Mesenchymal Transitions
Jing Yang, Robert A. Weinberg  Developmental Cell 
Chadrick E. Denlinger, MD, John S. Ikonomidis, MD, PhD, Carolyn E
Current View: Intestinal Stem Cells and Signaling
Figure 5 Drugs that target WNT signalling
Nat. Rev. Urol. doi: /nrurol
Stress Signals, Mediated by Membranous Glucocorticoid Receptor, Activate PLC/PKC/GSK-3β/β-catenin Pathway to Inhibit Wound Closure  Ivan Jozic, Sasa Vukelic,
Nat. Rev. Nephrol. doi: /nrneph
Volume 66, Issue 2, Pages (February 2017)
Volume 131, Issue 4, Pages (October 2006)
Caught in the Akt: Regulation of Wnt Signaling in the Intestine
Wnt/β-Catenin Signaling: Turning the Switch
Figure 1 WNT signalling pathways
Ryan S. Gray, Isabelle Roszko, Lilianna Solnica-Krezel 
Volume 148, Issue 7, Pages (June 2015)
P-Cadherin Regulates Human Hair Growth and Cycling via Canonical Wnt Signaling and Transforming Growth Factor-β2  Liat Samuelov, Eli Sprecher, Daisuke.
Figure 5 The mechanism underlying epithelial-to-mesenchymal
Volume 142, Issue 4, Pages (August 2010)
Mark S. Nanes, M.D., Ph.D., Caleb B. Kallen, M.D., Ph.D. 
Volume 59, Issue 5, Pages (November 2013)
Stress Signals, Mediated by Membranous Glucocorticoid Receptor, Activate PLC/PKC/GSK-3β/β-catenin Pathway to Inhibit Wound Closure  Ivan Jozic, Sasa Vukelic,
The Role of Smads in Skin Development
Dysregulation of Wnt/β-Catenin Signaling in Gastrointestinal Cancers
The Primary Cilium as a Complex Signaling Center
TIGIT-CD155 Interactions in Melanoma: A Novel Co-Inhibitory Pathway with Potential for Clinical Intervention  Karsten Mahnke, Alexander H. Enk  Journal.
Dongwon Kim, Luis A. Garza  Journal of Investigative Dermatology 
Woo Chi, Odysseas Morgan, Eleanor Wu, Bruce A. Morgan 
The Ying and Yang of Bacterial Signaling in Necrotizing Enterocolitis
Maksim V. Plikus  Journal of Investigative Dermatology 
Wnt/β-catenin signaling and kidney fibrosis
Joanne E. Sordillo, Peter Kraft, Ann Chen Wu, Maryam M. Asgari 
Volume 13, Issue 6, Pages R215-R216 (March 2003)
Global Patterns of Methylation in Sézary Syndrome Provide Insight into the Role of Epigenetics in Cutaneous T-Cell Lymphoma  Sean Whittaker  Journal of.
Keeping Transcriptional Activators under Control
Control of β-Catenin Stability
Noel S. Murcia, William E. Sweeney, Ellis D. Avner 
Fernanda Faião-Flores, Keiran S.M. Smalley 
Molecular Mechanisms Regulating Hair Follicle Development
Autosomal dominant polycystic kidney disease: the last 3 years
A Versatile Transcriptional Effector of Wingless Signaling
Cancer Stem Cells in Squamous Cell Carcinoma
Erik G. Huntzicker, Anthony E. Oro 
Laralynne Przybyla, Johnathon N. Lakins, Valerie M. Weaver 
Wnt/β-Catenin Signaling: Components, Mechanisms, and Diseases
Wnt/β-Catenin Signaling in Development and Disease
The Expanding Cosmos of Nuclear Receptor Coactivators
Volume 84, Issue 3, Pages (February 1996)
Cancer and Inflammation: An Aspirin a Day Keeps the Cancer at Bay
Polycystic kidney disease: Cell division without a c(l)ue?
A Wnt Survival Guide: From Flies to Human Disease
Wnt/β-Catenin Signaling, Disease, and Emerging Therapeutic Modalities
Volume 76, Issue 5, Pages (September 2009)
GPC5 Gene and Its Related Pathways in Lung Cancer
Volume 119, Issue 4, Pages (October 2000)
Volume 4, Issue 4, Pages (April 2009)
Volume 6, Pages (August 2018) Understanding How Wnt Influences Destruction Complex Activity and β-Catenin Dynamics  Abhirup Mukherjee, Neha Dhar,
Heads or tails: Wnts and anterior–posterior patterning
Periodic Activation of Wnt/β-Catenin Signaling Enhances Somatic Cell Reprogramming Mediated by Cell Fusion  Frederic Lluis, Elisa Pedone, Stefano Pepe,
Presentation transcript:

WNT Signaling in Cutaneous Squamous Cell Carcinoma: A Future Treatment Strategy?  Victoria Sherwood, Irene M. Leigh  Journal of Investigative Dermatology  Volume 136, Issue 9, Pages 1760-1767 (September 2016) DOI: 10.1016/j.jid.2016.05.108 Copyright © 2016 The Authors Terms and Conditions

Figure 1 WNT signaling and associated inhibitors. WNT/β-catenin–dependent signaling (left): in the absence of WNT binding to the FZD/LRP5/6 receptors, the signaling pool of β-catenin is maintained at low levels, mediated by the multiprotein destruction complex (comprising APC, Axin, GSK3β, CK1, and the multiprotein E3 ubiquitin ligase complex SCF). Upon WNT-receptor interaction, DVL inactivates the destruction complex, stabilizing β-catenin to promote TCF/LEF transcriptional activity. WNT/β-catenin–independent signaling (right, details not shown): this results in transcriptional changes, cytoskeletal rearrangement, changes in cell polarity/migration, and Ca2+ signaling. Inhibitors (red) include tankyrase inhibitors that stabilize the destruction complex through Axin degradation, DVL inhibitors, antagonists of β-catenin/TCF interactions, inhibitors that block Porcupine (required for WNT ligand secretion), FZD antibodies that block WNT binding, and the WNT5A (commonly a WNT/b-catenin–independent signaling ligand)especific inhibitory peptide Box5. Secreted WNT antagonists include Dickkopf proteins (DKKs) and secreted FZD-related proteins (SFRPs). Journal of Investigative Dermatology 2016 136, 1760-1767DOI: (10.1016/j.jid.2016.05.108) Copyright © 2016 The Authors Terms and Conditions

Figure 2 WNT signaling in cSCC. (a) WNT/β-catenin signaling is proposed to promote cell proliferation. Aside from WNT activation of β-catenin, ROCK-mediated inactivation of GSK3β has also been shown to increase β-catenin signaling. β-catenin also binds cadherin at adherens junctions, where reduced E-cadherin expression through EMT increases β-catenin signaling. Axl (a tyrosine kinase) promotes β-catenin signaling by increasing expression of EMT drivers (not shown). Loss of Notch also promotes β-catenin signaling (by a currently undefined mechanism). Stromal paracrine WNT/β-catenin signaling is also proposed to increase proliferation. WNT/β-catenin–independent signaling, initiated by WNT5A, promotes pro-invasive behavior in cSCC cells (through an undefined mechanism). Epigenetic loss of SFRP expression results in increased WNT signaling, but it is currently unknown whether this will affect both arms of the WNT network. (b) Summary of literature identifying how the WNT signaling network affects cSCC cells (as outlined in a). Mechanistic studies investigating the effects in human disease were used as a focus for this summary, but also highlighted is work generated from mouse models that supports the molecular functions identified in human tissue. See text for detailed discussion. cSCC, cutaneous squamous cell carcinoma; Dvl, Disheveled; EMT, epithelial-to-mesenchymal transition; ROCK, Rho-associated protein kinase; TCF, T-cell factor. Journal of Investigative Dermatology 2016 136, 1760-1767DOI: (10.1016/j.jid.2016.05.108) Copyright © 2016 The Authors Terms and Conditions